RAI1 Transcription Factor Activity Is Impaired in Mutants Associated with Smith-Magenis Syndrome

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Carmona Mora, Paulina ^a,d   Canales, Cesar P ^a,d   Cao, Lei ^a   Perez, Irene C ^a   Srivastava, Anand K ^b,c   Young, Juan I ^a   Walz, Katherina ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b GREENWOOD GENETIC CENTER   (United States)

^c CLEMSON UNIVERSITY   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RAI1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BDNF GENE; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; CELL NUCLEUS MATRIX; CELLULAR DISTRIBUTION; CHROMATIN; CONTROLLED STUDY; CYTOPLASM; ENHANCER REGION; GENE; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; RETINOIC ACID INDUCED 1 GENE; SMITH MAGENIS SYNDROME;

ANIMALS; CHROMATIN; ENHANCER ELEMENTS, GENETIC; GENES, REPORTER; HUMANS; LYMPHOCYTES; MICE; MUTANT PROTEINS; MUTATION; PHENOTYPE; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SMITH-MAGENIS SYNDROME; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84866521496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045155     Document Type: Article

References (36)

1. Greenberg F, Lewis RA, Potocki L, Glaze D, Parke J, et al. (1996) Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am J Med Genet 62: 247-254.
2. Laje G, Morse R, Richter W, Ball J, Pao M, et al. (2010) Autism spectrum features in Smith-Magenis syndrome. Am J Med Genet C Semin Med Genet 154C: 456-462.
3. Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH, (2003) Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 33: 466-468.
4. Bi W, Saifi GM, Shaw CJ, Walz K, Fonseca P, et al. (2004) Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome. Hum Genet 115: 515-524.
5. Girirajan S, Elsas LJ 2nd, Devriendt K, Elsea SH (2005) RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet 42: 820-828.
6. Bi W, Saifi GM, Girirajan S, Shi X, Szomju B, et al. (2006) RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome. Am J Med Genet A 140: 2454-2463.
7. Girirajan S, Truong HT, Blanchard CL, Elsea SH, (2009) A functional network module for Smith-Magenis syndrome. Clin Genet 75: 364-374.
8. Burns B, Schmidt K, Williams SR, Kim S, Girirajan S, et al. (2010) Rai1 haploinsufficiency causes reduced Bdnf expression resulting in hyperphagia, obesity and altered fat distribution in mice and humans with no evidence of metabolic syndrome. Hum Mol Genet 19: 4026-4042.
9. Truong HT, Dudding T, Blanchard CL, Elsea SH, (2010) Frameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literature. BMC Med Genet 11: 142.
10. Carmona-Mora P, Encina CA, Canales CP, Cao L, Molina J, et al. (2010) Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome. BMC Mol Biol 11: 63.
11. Seranski P, Hoff C, Radelof U, Hennig S, Reinhardt R, et al. (2001) RAI1 is a novel polyglutamine encoding gene that is deleted in Smith-Magenis syndrome patients. Gene 270: 69-76.
12. Nagase T, Nakayama M, Nakajima D, Kikuno R, Ohara O, (2001) Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 8: 85-95.
13. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, et al. (2004) The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res 14: 2121-2127.
14. Toulouse A, Rochefort D, Roussel J, Joober R, Rouleau GA, (2003) Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia. Genomics 82: 162-171.
15. Sutherland HG, Mumford GK, Newton K, Ford LV, Farrall R, et al. (2001) Large-scale identification of mammalian proteins localized to nuclear sub-compartments. Hum Mol Genet 10: 1995-2011.
16. Potocki L, Bi W, Treadwell-Deering D, Carvalho CM, Eifert A, et al. (2007) Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am J Hum Genet 80: 633-649.
17. Walz K, Paylor R, Yan J, Bi W, Lupski JR, (2006) Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2). J Clin Invest 116: 3035-3041.
18. Zhang F, Potocki L, Sampson JB, Liu P, Sanchez-Valle A, et al. (2010) Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS. Am J Hum Genet 86: 462-470.
19. Joober R, Benkelfat C, Toulouse A, Lafreniere RG, Lal S, et al. (1999) Analysis of 14 CAG repeat-containing genes in schizophrenia. Am J Med Genet 88: 694-699.
20. Hayes S, Turecki G, Brisebois K, Lopes-Cendes I, Gaspar C, et al. (2000) CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet 9: 1753-1758.
21. van der Zwaag B, Franke L, Poot M, Hochstenbach R, Spierenburg HA, et al. (2009) Gene-network analysis identifies susceptibility genes related to glycobiology in autism. PLoS One 4: e5324.
22. Girirajan S, Vlangos CN, Szomju BB, Edelman E, Trevors CD, et al. (2006) Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum. Genet Med 8: 417-427.
23. Vieira GH, Rodriguez JD, Carmona-Mora P, Cao L, Gamba BF, et al. (2012) Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith-Magenis syndrome. Eur J Hum Genet 20: 148-154.
24. Vilboux T, Ciccone C, Blancato JK, Cox GF, Deshpande C, et al. (2011) Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion. PLoS One 6: e22861.
25. Edelman EA, Girirajan S, Finucane B, Patel PI, Lupski JR, et al. (2007) Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clin Genet 71: 540-550.
26. Silver PA, Keegan LP, Ptashne M, (1984) Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization. Proc Natl Acad Sci U S A 81: 5951-5955.
27. Carmona-Mora P, Walz K, (2010) Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior. Curr Genomics 11: 607-617.
28. Juyal RC, Figuera LE, Hauge X, Elsea SH, Lupski JR, et al. (1996) Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. Am J Hum Genet 58: 998-1007.
29. Potocki L, Shaw CJ, Stankiewicz P, Lupski JR, (2003) Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)]. Genet Med 5: 430-434.
30. Vlangos CN, Yim DK, Elsea SH, (2003) Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally? Mol Genet Metab 79: 134-141.
31. Gropman AL, Elsea S, Duncan WC Jr, Smith AC, (2007) New developments in Smith-Magenis syndrome (del 17p11.2). Curr Opin Neurol 20: 125-134.
32. Darvekar S, Johnsen SS, Eriksen AB, Johansen T, Sjottem E, (2012) Identification of two independent nucleosome-binding domains in the transcriptional co-activator SPBP. Biochem J 442: 65-75.
33. Bienz M, (2006) The PHD finger, a nuclear protein-interaction domain. Trends Biochem Sci 31: 35-40.
34. Mellor J, (2006) It takes a PHD to read the histone code. Cell 126: 22-24.
35. Peng J, Wysocka J, (2008) It takes a PHD to SUMO. Trends Biochem Sci 33: 191-194.
36. He DC, Nickerson JA, Penman S, (1990) Core filaments of the nuclear matrix. J Cell Biol 110: 569-580.